Investigation on effect of mixed herbal medicines (fennel,chamomile,saffron) on menopausal syndrome,hormonal changing and quality of life
Not Applicable
- Conditions
- Menopause.is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. This is the American ICD-10-CM version of N95.1. Other international versions of ICD-10 N95.1 may differ.N 95.1
- Registration Number
- IRCT2016092429950N1
- Lead Sponsor
- Vice Chancellor for Research and Technology of Mashhad university of medical science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
lack of menstruation in last 12 months; having tested showed the evidence of menopause; having menopausal syndrome; the range of the age is between 45 - 65 years.
Exclusion criteria : using anti-anxiety drugs; using antidepressants; using hormones such as: estrogen and progesterone in the last 6 months; using anticoagulant and NSAIDs such as: ibuprofen; having asthma and allergies; thyroid diseases; psychosomatic disorders; pheochromocytoma; carcinoma; leukemia; cancer; lack of proper use of herbal medicines in this study; creating skin irritation and allergy drug.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Menopausal syndrome. Timepoint: At the beginning of the study,6 weeks later and 12 weeks later at the end of intervention. Method of measurement: Menopause Rating Scale (MRS).;Quality of life. Timepoint: At the beginning of the study,6 weeks later and 12 weeks later at the end of intervention. Method of measurement: Quality of life questioner(QOL).;Hormones changes. Timepoint: At the beginning of the study and 12 weeks later at the end of intervention. Method of measurement: Laboratory measurements.
- Secondary Outcome Measures
Name Time Method Depression. Timepoint: at the beginning,6 weeks later and 12 weeks later at the end of intervention. Method of measurement: Beck questioner.;Insomnia. Timepoint: at the beginning,6 weeks later and 12 weeks later at the end of intervention. Method of measurement: ISI questioner.